REQUEST A DEMO
Total
USD $0.00
Search more companies

Vifarma - Js Cia.Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: Vifarma - Js Cia.Ltda Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Vifarma - Js Cia.Ltda is a company based in Ecuador, with its head office in Quito. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Vifarma - Js Cia.Ltda was incorporated on May 29, 2017. 6 (2021) employees currently work for Vifarma - Js Cia.Ltda. From the latest financial highlights, Vifarma - Js Cia.Ltda reported a net sales revenue increase of 17.2% in 2022. There was a total growth of 2.82% in Vifarma - Js Cia.Ltda’s total assets over the same period. In 2022, Vifarma - Js Cia.Ltda’s net profit margin decreased by 2.55%.

Headquarters
Juan Gonzales N144, Vizcaya Ii Bldg.
Quito; Pichincha;

Contact Details: Purchase the Vifarma - Js Cia.Ltda report to view the information.

Website: http://www.vifarma.com.ec

Basic Information
Total Employees:
Purchase the Vifarma - Js Cia.Ltda report to view the information.
Outstanding Shares:
Purchase the Vifarma - Js Cia.Ltda report to view the information.
Registered Capital:
Purchase the Vifarma - Js Cia.Ltda report to view the information.
Incorporation Date:
May 29, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
75%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Vifarma - Js Cia.Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
17.2%
Total operating revenue
17.2%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-77.28%
Total assets
2.82%
Total equity
-21.99%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-2.55%
Return on Equity (ROE)
-9.13%
Debt to Equity Ratio
2.58%
Quick Ratio
0.08%
Cash Ratio
0.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?